Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News

Tag: glycemic variability


Impact of short-term glycemic variability on risk of all-cause mortality in type 2 diabetes patients with well-controlled glucose profile by continuous glucose monitoring: a prospective cohort study

June 1st 2022

Greater %CV was associated with increased risk for all-cause mortality even among patients with seemingly well-controlled glucose status (Diabetes Research and Clinical Practice)

Categories: Monitoring, News
Tags: glycemic variability, SGLT2 inhibitors

Categories: Monitoring
Tags: glycemic variability, SGLT2 inhibitors

Acute glycemic variability and mortality of patients with acute stroke: a meta-analysis

May 11th 2022

Higher acute GV may be an independent risk factor of early mortality in patients with acute stroke (Diabetology & Metabolic Syndrome)

Categories: Cardiovascular, Monitoring, News
Tags: glycemic variability, stroke

Categories: Cardiovascular, Monitoring
Tags: glycemic variability, stroke

The Role of Glucagon in Glycemic Variability in Type 1 Diabetes: A Narrative Review

December 20th 2021

There is growing evidences to illustrate the contribution of glucagon secretion to the glycemic variability in patients with T1DM, which may promote the development of new treatment strategies aiming to mitigate glycemic variability associated with aberrant glucagon secretion (Metabolic Syndrome and Obesity)

Categories: News, Pathology, Treatment
Tags: glucagon, glycemic variability, Type 1 Diabetes

Categories: Pathology, Treatment
Tags: glucagon, glycemic variability, Type 1 Diabetes

Association of glycemic variability assessed by continuous glucose monitoring with subclinical diabetic polyneuropathy in type 2 diabetes

September 3rd 2021

The SDgluc is a significant independent contributor to subclinical diabetic polyneuropathy, in addition to conventional risk factors including diabetes duration and HbA1c (Journal of Diabetes Investigation)

Categories: Neuropathy, News
Tags: CGM, glycaemic control, glycemic variability, Type 2 Diabetes

Categories: Neuropathy
Tags: CGM, glycaemic control, glycemic variability, Type 2 Diabetes

The association between hypoglycemia and glycemic variability in elderly patients with type 2 diabetes: a prospective observational study

April 5th 2021

Among elderly patients with type 2 diabetes, CV reflected TBR ≥ 1% most appropriately among the GV indices examined (Diabetology & Metabolic Syndrome)

Categories: Monitoring, News
Tags: glycemic variability, hypoglycemia, Type 2 Diabetes

Categories: Monitoring
Tags: glycemic variability, hypoglycemia, Type 2 Diabetes

Glycemic Variability Is a Powerful Independent Predictive Factor of Midterm Major Adverse Cardiac Events in Patients With Diabetes With Acute Coronary Syndrome

February 8th 2019

A GV cutoff value of >2.70 mmol/L was the strongest independent predictive factor for midterm MACE in patients with diabetes and ACS  (Diabetes Care)

Categories: Cardiovascular, News
Tags: glycemic variability

Categories: Cardiovascular
Tags: glycemic variability

Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes

April 25th 2018

Assessment of glycemia should go beyond HbA1c and incorporate measures of GV and glycemic indices. %CVSMBG in type 1 diabetes and LBGISMBG or a combination of HbA1c and %CVSMBG in type 2 diabetes discriminated hypoglycemia well. In defining hypoglycemia risk using GV and glycemic indices, diabetes subtypes and data source (CGM vs. SMBG) must be considered (Diabetes Technology and Therapeutics)

Categories: Monitoring, News
Tags: glycemic variability, Type 1 Diabetes, Type 2 Diabetes

Categories: Monitoring
Tags: glycemic variability, Type 1 Diabetes, Type 2 Diabetes

Diabetic Kidney Disease: Is There a Role for Glycemic Variability?

February 15th 2018

Glycemic variability may be a factor in the development of DKD, but definitive evidence is lacking. Currently, all available glycemic biomarkers, including A1C, have limitations and in the setting of DKD and should be used cautiously. Emerging data suggest that personal and professional CGM will play an important role in managing diabetes in patients with DKD, where risk of hypoglycemia is high (Current Diabetes Reports)

Categories: Nephropathy, News
Tags: glycemic variability

Categories: Nephropathy
Tags: glycemic variability

The Potential Effect of Ultra-Long Insulin Degludec on Glycemic Variability

July 1st 2017

Data from PK and PD studies combined with the results of several clinical trials suggest that IDeg has the potential to improve the management of T1D and T2D patients by allowing some flexibility in the administration schedule, by reducing the frequency of hypoglycemic episodes and, possibly, by minimizing GV (Diabetes Research and Clinical Practice)

Categories: Medication, News
Tags: degludec, glycemic variability, hypoglycemia, insulin

Categories: Medication
Tags: degludec, glycemic variability, hypoglycemia, insulin

Relationship between daily and day-to-day glycemic variability and increased oxidative stress in type 2 diabetes

October 27th 2016

Oxidative stress is associated with daily and day-to-day glucose variability in patients with T2DM (Diabetes Research and Clinical Practice)

Categories: Monitoring, News
Tags: glycemic variability, oxidative stress, Type 2 Diabetes

Categories: Monitoring
Tags: glycemic variability, oxidative stress, Type 2 Diabetes

The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes

June 4th 2015

CV in CGM and all parameters of HbA1c variability were independently associated with the presence of CAN in patients with inadequately controlled type 2 diabetes requiring CGM (Cardiovascular Diabetology)

Categories: Cardiovascular, News
Tags: glycemic variability, Type 2 Diabetes

Categories: Cardiovascular
Tags: glycemic variability, Type 2 Diabetes

Glycemic Variability Is Associated With Reduced Cardiac Autonomic Modulation in Women With Type 2 Diabetes

January 13th 2015

In patients with newly diagnosed and well-controlled type 2 diabetes, increased glycemic variability was associated with reduced cardiac autonomic modulation in women but not in men (Diabetes Care)

Categories: Cardiovascular, News
Tags: glycemic variability, Type 2 Diabetes

Categories: Cardiovascular
Tags: glycemic variability, Type 2 Diabetes

The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c

January 6th 2015

There was a close relationship between glycemic variability evaluated by MAGE and DPN in type 2 diabetes with well-controlled HbA1c (Diabetology & Metabolic Syndrome)

Categories: Neuropathy, News
Tags: glycemic variability

Categories: Neuropathy
Tags: glycemic variability

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Gold Sponsors

Napp DiabetesAstraZenecaNovo NordiskBoehringer Ingelheim

Silver Sponsors

Abbott Diabetes CareWelsh Endocrinology and Diabetes Society (WEDS)About Ascensia Diabetes Care

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Categories

  • Audits
  • Bariatric
  • Biochemistry
  • Cardiovascular
  • Devices
  • Diagnosis
  • Diet
  • Education
  • Epidemiology
  • Genetics
  • Gestational
  • Guidance
  • Guidelines
  • Hepatology
  • Hypertension
  • Immunology
  • Management
  • Media
  • Medication
  • Meetings
  • Monitoring
  • Nephrology
  • Neuropathy
  • Nephropathy
  • Obesity
  • Ophthalmology
  • Paediatrics
  • Pathology
  • Pharma
  • Pharmacology
  • Physiology
  • Podiatry
  • Prediabetes
  • Prevalence
  • Prevention
  • Psychological
  • Reports
  • Research
  • Screening
  • Sponsorship
  • Technology
  • Testing
  • Transplantation
  • Treatment
  • Wound Care

To see all articles associated with a category just click on the category name.

Popular Tags

ADA BMI canagliflozin CGM CKD closed-loop COVID-19 dapagliflozin DPP4 DPP4 inhibitors Empagliflozin exenatide GLP-1 RA GLP1 glycaemic control HbA1c heart failure hyperglycemia hypoglycemia incretin insulin insulin pump Insulin resistance Ketoacidosis liraglutide metformin microvascular mortality NAFLD NICE pioglitazone retinopathy semaglutide SGLT2 inhibitors sitagliptin statin sulfonylureas Type 1 Diabetes Type 2 Diabetes Vitamin D

To see all articles associated with a tag just click on the tag name.

Complete list of Tags ››

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Copyright © 2022 Glycosmedia Partnership